INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $18,000 | +38.5% | 3,801 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -65.8% | 3,801 | 0.0% | 0.00% | – |
| Q3 2018 | $38,000 | -7.3% | 3,801 | -31.2% | 0.00% | – |
| Q2 2018 | $41,000 | +24.2% | 5,528 | 0.0% | 0.00% | – |
| Q1 2018 | $33,000 | -62.1% | 5,528 | -40.9% | 0.00% | – |
| Q4 2017 | $87,000 | +24.3% | 9,348 | +18.8% | 0.00% | – |
| Q3 2017 | $70,000 | -30.0% | 7,870 | 0.0% | 0.00% | – |
| Q2 2017 | $100,000 | +19.0% | 7,870 | 0.0% | 0.00% | – |
| Q1 2017 | $84,000 | +15.1% | 7,870 | -1.2% | 0.00% | – |
| Q4 2016 | $73,000 | +5.8% | 7,965 | +35.5% | 0.00% | – |
| Q3 2016 | $69,000 | -11.5% | 5,877 | -5.9% | 0.00% | – |
| Q2 2016 | $78,000 | -22.0% | 6,247 | 0.0% | 0.00% | – |
| Q1 2016 | $100,000 | -35.1% | 6,247 | +16.3% | 0.00% | – |
| Q4 2015 | $154,000 | +2.0% | 5,371 | 0.0% | 0.00% | – |
| Q3 2015 | $151,000 | +16.2% | 5,371 | +47.4% | 0.00% | – |
| Q2 2015 | $130,000 | +22.6% | 3,644 | +100.0% | 0.00% | – |
| Q1 2015 | $106,000 | +34.2% | 1,822 | 0.0% | 0.00% | – |
| Q4 2014 | $79,000 | +11.3% | 1,822 | 0.0% | 0.00% | – |
| Q3 2014 | $71,000 | – | 1,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 3,028,354 | $30,526,000 | 0.37% |
| Engineers Gate Manager LP | 96,105 | $969,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,600 | $621,000 | 0.06% |
| GAM Holding AG | 83,940 | $846,000 | 0.03% |
| SHELL ASSET MANAGEMENT CO | 90,282 | $910,000 | 0.02% |
| SFMG, LLC | 11,994 | $107,000 | 0.02% |
| QS Investors, LLC | 159,133 | $1,604,000 | 0.02% |
| Winslow, Evans & Crocker, Inc. | 4,060 | $42,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 285,646 | $2,879,000 | 0.01% |
| PEAK6 Investments LLC | 225,800 | $2,276,000 | 0.01% |